This event has taken place and this page is here for information only. See our Events page
for upcoming events, or the see our event reports
for more on past events.
Wednesday 26 April 2017
Maximising the agency & procurement relationship in pharma
The Royal Society of Medicine, London
Wednesday 26th April 2017
13:30 - 17:00
The Royal Society of Medicine
1 Wimpole Street
Procurement, both generally and in pharma, is often misunderstood by agencies.
We have had requests from both agencies (to allow them to maximise this relationship) and pharma (to allow them to network with each other) to run an event with this in mind.
If you are an agency employee who deals with pharma procurement, then this event will help you understand more about the procurement function in pharma and how you should improve the way you approach the relationship.
If you work in pharma, come to hear what experts in pharma procurement are saying and meet pharma colleagues working in this area.
There will be core presentations with Q&A and also panel discussions with additional contributions.
Book your place online now
||Arrival and coffee
Introduction – Maximising the agency & procurement relationship in pharma
Carwyn Jones, Director, PM Society
1. Global vs Local - Procurement Strategies & Supplier Diversity
Justin Lambert - Head of Procurement - Roche Products Limited
Justin will discuss the positives and negatives of global supplier selection, when is it appropriate to select suppliers at a global level and when should the responsibility for selecting suppliers remain at a local level. The importance of having a diverse supplier base, and the impact global supplier selection has on supplier diversity initiatives.
2. 2020 Vision of Procurement & What Pharma Procurement Need from Agencies.
Malik Akhtar – Procurement
Malik will discuss Procurement’s transformation, from a tactical transactional function, to trusted business partners and advisers. Procurement’s continued direction of travel towards 2020 and beyond. How Procurement engages with agencies has changed, as will the role agencies will be asked to play to support Procurement ambitions.
3. The Procurement function’s KPIs and the value they bring to the business & Procurement supplier selection process and strategy
Daniel Roberts – ex-BMS procurement
As someone who only left pharma in 2016, Daniel brings a unique perspective on how the Procurement function is measured within the organisation, and the value procurement can bring to the business. Differentiate between creating value and cost reduction. The Procurement supplier selection process, why it exists and the impact this has on the business and agencies.
4. PANEL DISCUSSION – Speakers PLUS:
2 additional pharma procurement specialists
5. Where procurement is getting it right and what agencies should do about this
David Hunt, CEO, Havas Lynx & Carwyn Jones, Partner, OPEN Health
David and Carwyn will jointly present on their experiences with procurement, where it has gone well, and where it has gone not so well. They will also reveal examples of agency good practice based on direct pharma procurement feedback.
6. PANEL DISCUSSION – Speakers PLUS:
Chris Edmonds, MD, emotive + Martin Brass, MD, Blue Latitude Health
DRINKS & NETWORKING